We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

PURITAN MEDICAL

Puritan Medical Products is a manufacturer of healthcare, diagnostic and critical environment products. Its portfolio... read more Featured Products: More products

Download Mobile App




Puritan Medical Products Showcasing Innovation at AMP2025 in Boston

By LabMedica International staff writers
Posted on 05 Nov 2025

Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15. More...

Known globally as the “Swab Experts,” Puritan continues to lead the way in developing innovative, reliable, and industry-specific specimen collection and transport solutions.

With a legacy spanning decades, Puritan has built its reputation by providing a wide range of swab products designed to serve multiple industries. Its offerings span diagnostic, medical, and genetic applications in healthcare to precision-engineered, static-free swabs used for delicate tasks in the semiconductor sector. The company also develops transport media, ensuring complete solutions for accurate specimen collection, preservation, and analysis.

In 2025, Puritan has already showcased its solutions at several major international events, including ESCMID Global 2025 in Vienna and ADLM 2025 in Chicago. These appearances highlighted the company’s commitment to advancing diagnostic tools worldwide, fostering collaboration with healthcare professionals, and introducing next-generation specimen collection technologies.

At AMP2025, Puritan is introducing its latest advancement: the Puritan® PurSafe Plus® Collection & Transport System, featuring Puritan’s patented HydraFlock® flocked swab. PurSafe Plus® will officially launch in the coming months and will debut exclusively in the U.S. before expanding to additional markets. 

PurSafe Plus® is specifically engineered for the collection, inactivation, and preservation of human upper respiratory specimens suspected of containing SARS-CoV-2. This versatile system supports specimen collection, transport, and storage at both 2–4°C and 25–30°C, offering laboratories flexibility without compromising integrity. Each PurSafe Plus® kit includes one polypropylene vial containing 1 mL of MK buffer, a proven buffer solution preservative; one sterile, pre-scored HydraFlock® flocked swab available in three styles for nasal, nasopharyngeal, and throat collection; and media-only options for laboratories requiring flexible workflows.

HydraFlock® technology provides a distinct advantage in clinical diagnostics, as its unique flocking design increases fiber surface area, enabling superior sample collection and release. This results in more reliable sample recovery, greater availability of analyte, and ultimately more accurate test results—a critical factor in clinical decision-making.

Puritan invites attendees to visit the company’s booth #1129 at AMP2025 in Boston, where attendees can learn more about the company’s comprehensive line of specimen collection and transport devices, and experience firsthand the difference that innovation, expertise, and quality make in diagnostics.

Related Links:
Puritan Medical Products


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more

Microbiology

view channel
Image: New EMBL-led research identifies a robust gut microbiome signature linked to colorectal cancer, consistent across populations, sequencing methods & age groups, and tied to lower dietary fiber intake. (Photo courtesy of Daniela Velasco/EMBL)

Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer

Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.